On-demand treatment of icatibant in a patient of hereditary angioedema with KNG1 mutation. [PDF]
Yao W, Yang B, Wang H.
europepmc +1 more source
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis. [PDF]
Craig TJ +16 more
europepmc +1 more source
Association of muscle instability and long-term prophylaxis in hereditary angioedema. [PDF]
Hollers E +9 more
europepmc +1 more source
Psychometric validation of the Angioedema Quality of Life Questionnaire (AE-QoL) for hereditary angioedema. [PDF]
Feld AJ +5 more
europepmc +1 more source
Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.
Watt M +6 more
europepmc +1 more source
FXII Frameshift Variant Does Not Cause Hereditary Angioedema with Normal C1 Inhibitor. [PDF]
Miyata T, Horiuchi T, Hide M.
europepmc +1 more source
Drug Patterns and Economic Costs Among Patients with Hereditary Angioedema. [PDF]
Kutrieb E +5 more
europepmc +1 more source
The International/Canadian hereditary angioedema guideline. [PDF]
Betschel S +50 more
europepmc +1 more source
Endothelial barrier disorder in hereditary angioedema: molecular mechanisms and therapeutic implications. [PDF]
Zhou N, Wu J, Zhi Y.
europepmc +1 more source
Expert consensus on the long-term use of lanadelumab in hereditary angioedema: Toward harmonized care. [PDF]
Aygören-Pürsün E +7 more
europepmc +1 more source

